Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC LAQ824 (NVP-LAQ824,Dacinostat) 404951-53-7 200mg
SDP

Supplier:  Apexbio Technology LLC A4103200

Encompass_Preferred

LAQ824 (NVP-LAQ824 Dacinostat CAS 404951-53-7) is a synthetic derivative of 4-aminomethylcinnamic hydroxamic acid that functions as a histone deacetylase (HDAC) inhibitor It exhibits potent HDAC inhibition with an IC50 of 0 03 M LAQ824 has demonstrated the ability to inhibit proliferation across a range of human cancer cell lines including colorectal (H1299 HCT116) breast (MDA435 SKBR-3 BT-474 MB-468) prostate (DU145 PC3) and non-small cell lung (A549) cancer models with IC50 values below 1 M Additionally it induces apoptosis in breast cancer cells and suppresses multiple myeloma cell growth in a time- and dose-dependent manner LAQ824 is widely utilized in cancer research to study epigenetic regulation and evaluate HDAC inhibitor-based therapeutic strategies

Catalog No. 50-000-96740


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.